Inito, a YC alum that helps women track fertility hormones quickly at home, has raised $6 million in Series A funding led by Fireside Ventures. The startup’s fertility monitor and kit is designed to ...

Powered by patented Spectral Mapping technology, the new reader measures four critical fertility hormones with the most precision1, delivering results to your phone while you go about your morning.

Inito, an at-home diagnostics startup, on Thursday raised $29 million in Series B funding as it seeks to broaden its hormone-testing platform beyond fertility and push deeper into clinical-grade tests ...

Fertility startup Inito has raised $29 million in Series B funding to scale its at-home health diagnostics platform and use AI-designed antibodies to unlock new kinds of at-home tests. When the ...

India’s expanding health-tech ecosystem continues to attract investor confidence as Inito raises $29 million in Series B funding, led by Bertelsmann India Investments (BII) with participation from ...

The company claims that Inito is the only ovulation test that measures estrogen and luteinising hormone levels to predict fertile days, as well as progesterone to confirm if ovulation has actually ...

(MENAFN- ForPressRelease) India, December 11, 2025: Inito, the company on a mission to simplify health with at-home diagnostics, today announced it has raised $29 million in Series B funding, led by ...

First At-Home test that measures the actual value of fertility hormones, tracks fertile days and also confirms if ovulation actually occurs. PALO ALTO, Calif., July 20, 2021 /PRNewswire-PRWeb/ -- ...

The MarketWatch News Department was not involved in the creation of this content. Powered by patented Spectral Mapping technology, the new reader measures four critical fertility hormones with the ...